| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |